Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors

导出原文传递

翻译打印收藏纠错

作者： Reddy,M.B. ^[1] ; Morcos,P.N. ^[2] ; LePogam,S. ^[3] ; Ou,Y. ^[4] ; Frank,K. ; Lave,T. ; Smith,P. ; Roche,H.-L.

作者单位： Hoffmann-La Roche, Basel, Switzerland ^[1] Roche Palo Alto, Palo Alto, CA, United States, Theravance, South San Francisco, CA, United States ^[2] Hoffmann-La Roche Inc., Nutley, NJ, United States ^[3] Hoffmann-La Roche Inc., Nutley, NJ, United States, Roche Palo Alto, Palo Alto, CA, United States ^[4]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Antimicrobial Agents and Chemotherapy

2012年56卷6期

3144-3156页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors

Antimicrobial Agents and Chemotherapy

相似文献

Antimicrobial Agents and Chemotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors

Antimicrobial Agents and Chemotherapy

相似文献

Antimicrobial Agents and Chemotherapy

相关期刊

检索历史清除